Chronic Phase Chronic Myelogenous Leukemia Completed Phase 1 Trials for Bryostatin 1 (DB11752)

IndicationStatusPhase
DBCOND0028870 (Chronic Phase Chronic Myelogenous Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00012376Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerTreatment